Revance Therapeutics Inc
NASDAQ:RVNC

Watchlist Manager
Revance Therapeutics Inc Logo
Revance Therapeutics Inc
NASDAQ:RVNC
Watchlist
Price: 3.65 USD
Market Cap: 381m USD

Intrinsic Value

The intrinsic value of one RVNC stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.65 USD, Revance Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

RVNC Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Revance Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

RVNC looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if RVNC is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about RVNC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RVNC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Revance Therapeutics Inc.

Explain Valuation
Compare RVNC to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RVNC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Revance Therapeutics Inc

Current Assets 329.7m
Cash & Short-Term Investments 184.1m
Receivables 48.3m
Other Current Assets 97.3m
Non-Current Assets 131.9m
PP&E 77m
Intangibles 7.6m
Other Non-Current Assets 47.3m
Current Liabilities 80m
Accounts Payable 12.3m
Accrued Liabilities 39.2m
Other Current Liabilities 28.5m
Non-Current Liabilities 544.5m
Long-Term Debt 421m
Other Non-Current Liabilities 123.5m
Efficiency

Free Cash Flow Analysis
Revance Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Revance Therapeutics Inc

Revenue
247m USD
Cost of Revenue
-67.7m USD
Gross Profit
179.4m USD
Operating Expenses
-346.9m USD
Operating Income
-167.6m USD
Other Expenses
-16.9m USD
Net Income
-184.4m USD
Fundamental Scores

RVNC Profitability Score
Profitability Due Diligence

Revance Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Revance Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

RVNC Solvency Score
Solvency Due Diligence

Revance Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

Revance Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RVNC Price Targets Summary
Revance Therapeutics Inc

There are no price targets for RVNC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Revance Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RVNC is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RVNC Insider Trading
Buy and sell transactions by insiders

RVNC News

Other Videos
What is the Intrinsic Value of one RVNC stock?

The intrinsic value of one RVNC stock under the Base Case scenario is hidden USD.

Is RVNC stock undervalued or overvalued?

Compared to the current market price of 3.65 USD, Revance Therapeutics Inc is hidden .

Back to Top